Shareholding disclosure

Kuros Biosciences AG

Collectively declared rate

9.5%

Threshold

Crossed upwards

Timeline

Published

23.01.2016

Transaction

22.01.2016

Voting rights breakdown

Voting rights acquired9.5%
Voting rights sold0%
Below threshold0%

Declared beneficial owners · 3

A single, collectively filed disclosure: the voting-rights rate applies to the whole group, not to each person.

Notice details

CategoryGroup of shareholders
ExchangeXSWX

Notification ID

TBG1M00016

Beneficial owner

Martijn Kleijwegt

Declared address

Martijn Kleijwegt, Amsterdam

The purchase positions of the respective shareholder or group of shareholders (as applicable) which arose on December 1, 2015, as a result of such shareholder or group of shareholder having undertaken to exchange shares in Kuros Biosurgery Holding AG against New Shares at the closing of the Combination, which have been disclosed via the database maintained by SIX Swiss Exchange, have lapsed as a result of the Combination. Messrs. Martijn Kleijwegt, Amsterdam, The Netherlands, René Kuijten, Baarn, The Netherlands, and Joachim Rothe, Munich, Germany, control the exercise of voting rights in the shares held by LSP V Coöperatieve U.A., a multi-investor fund.

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open